Healt


 Telix Pharmaceuticals (ASX:TLX) Strengthens Cancer Pipeline with FAP-Targeting Acquisition

Telix Pharmaceuticals (ASX:TLX) Strengthens Cancer Pipeline with FAP-Targeting Acquisition

March 12, 2025 02:38 PM AEDT| By Team Kalkine Media

Highlights,Strategic Expansion:,Telix,Pharmaceuticals (,ASX:TLX,) enhances its nuclear medicine pipeline.,New,Theranostic,Focus:,Addition of TLX400 advances bladder cancer and pan-cancer applications.,Global Potential:,Clinically validated radiopharm...

 Healthcare Stocks to Watch: A Look at (ASX:SHL) and (ASX:PME) in 2025

Healthcare Stocks to Watch: A Look at (ASX:SHL) and (ASX:PME) in 2025

March 12, 2025 01:12 PM AEDT| By Team Kalkine Media

Highlights,Sonic Healthcare,has seen a decline of 6.2% since the start of 2025, while (,ASX:PME,),remains,25.7% below its 52-week high.,Sonic Healthcare is a global leader in pathology and diagnostic services, serving multiple regions.,Pro Medicus sp...

 Beamtree Holdings Limited Faces a Challenging Period

Beamtree Holdings Limited Faces a Challenging Period

March 11, 2025 07:35 PM AEDT| By Team Kalkine Media

Highlights,Beamtree Holdings Limited (ASX: BMT) shares slump by 28% over the past month.,Company's Price-to-Sales ratio is low compared to industry standards.,Revenue growth forecasts trail the industry expectations significantly.,In recent weeks, Be...

 Cyclopharm Limited (ASX:CYC): Navigating a Challenging Month

Cyclopharm Limited (ASX:CYC): Navigating a Challenging Month

March 11, 2025 07:34 PM AEDT| By Team Kalkine Media

Highlights,Cyclopharm's stock saw a 38% decline over the past month.,Current price-to-sales (P/S) ratio stands at 5.6x.,Future growth seen at 50% annually over the next three years.,Cyclopharm Limited (ASX:CYC) has recently experienced a challenging...

 Investors drive Mesoblast (ASX:MSB) down by 18% this week, potentially due to the company's rising losses.

Investors drive Mesoblast (ASX:MSB) down by 18% this week, potentially due to the company's rising losses.

March 11, 2025 07:32 PM AEDT| By Team Kalkine Media

Highlights:,Mesoblast Limited has experienced significant stock price movement, with a notable increase over the past year.,A recent decline contrasts with long-term gains, prompting further examination of revenue trends and market sentiment.,Insider...

 ECS Botanics Holdings (ASX:ECS): A Deeper Dive into the P/S Ratio

ECS Botanics Holdings (ASX:ECS): A Deeper Dive into the P/S Ratio

March 11, 2025 07:30 PM AEDT| By Team Kalkine Media

Highlights,ECS Botanics Holdings (ASX:ECS) displays a low price-to-sales (P/S) ratio.,Investors show concerns over declining revenue trends.,Potential for future growth remains uncertain amid industry comparisons.,For those eyeing the pharmaceutical...

 PolyNovo (ASX:PNV) Embarks on Leadership Transition: CEO Steps Down

PolyNovo (ASX:PNV) Embarks on Leadership Transition: CEO Steps Down

March 11, 2025 02:32 PM AEDT| By Team Kalkine Media

Highlights,Leadership Change:,CEO Swami,Raote,steps down,immediately,; interim CEO appointed.,Board Review:,Governance and succession planning in focus.,CEO Remuneration:,Salary and share details,disclosed,.,PolyNovo (ASX:PNV) has announced a signifi...

 EZZ Life Sciences Experiences Decline as It Expands Manufacturing Operations into the US.

EZZ Life Sciences Experiences Decline as It Expands Manufacturing Operations into the US.

March 11, 2025 02:32 PM AEDT| By Team Kalkine Media

Highlights,EZZ Life Sciences (ASX:EZZ) enters the U.S. market with local manufacturing operations.,Strategic partnership with GLSP ensures compliance with FDA and international standards.,Market response reflects cautious investor sentiment amid econ...

 4DMedical (ASX:4DX) Secures Multi-Year Contract Extension with Cleveland Clinic, Strengthening Market Position

4DMedical (ASX:4DX) Secures Multi-Year Contract Extension with Cleveland Clinic, Strengthening Market Position

March 11, 2025 01:08 PM AEDT| By Team Kalkine Media

Highlights,4DMedical (ASX:4DX) renews a three-year contract with Cleveland Clinic.,Agreement,ensures continued growth in revenue per site.,Strengthened positioning in respiratory imaging technology.,4DMedical (ASX:4DX) has successfully secured a thre...

 Dr. Boreham's Crucible: This Company Targeting a Rare Blood Disease Aims to Impress Investors with Its Strongest Effort

Dr. Boreham's Crucible: This Company Targeting a Rare Blood Disease Aims to Impress Investors with Its Strongest Effort

March 11, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights:,Syntara shifts from its Bronchitol program to advancing treatments for myelofibrosis.,Phase I/IIa trial data for SNT-5505 indicates effectiveness with improved tolerability.,Strategic restructuring aligns with expanded research initiative...

 Big Changes in ASX 50: Pro Medicus and Sigma Healthcare Join, Mineral Resources and Ramsay Exit

Big Changes in ASX 50: Pro Medicus and Sigma Healthcare Join, Mineral Resources and Ramsay Exit

March 10, 2025 01:20 PM AEDT| By Team Kalkine Media

Highlights,Pro Medicus (,ASX:PME,) and Sigma Healthcare (,ASX:SIG,),set,to join ASX 50.,Mineral Resources (,ASX:MIN,) and Ramsay Health Care (,ASX:RHC,) to exit the index.,Changes to ASX 100 and ASX 200 indices announced, effective March 24.,The late...

 PolyNovo Shares Rebound After Addressing Allegations Against Chair

PolyNovo Shares Rebound After Addressing Allegations Against Chair

March 10, 2025 12:22 PM AEDT| By Team Kalkine Media

Highlights:,Share Movement:,PolyNovo shares climbed 3.8% after falling 13% on Friday.,CEO Departure:,The company confirmed CEO Swami Raote's exit amid reports of a bullying probe involving the chair.,Governance Measures:,PolyNovo has brought in legal...

 PolyNovo Shares Surge as Governance Measures Reassure Investors

PolyNovo Shares Surge as Governance Measures Reassure Investors

March 10, 2025 12:16 PM AEDT| By Team Kalkine Media

Highlights,PolyNovo,(PNV) shares rebound following governance updates,Board implements workplace training and succession planning,Former Westpac chair Lindsay,Maxsted,brought in for governance advisory,PolyNovo (ASX:PNV) saw a sharp uptick in its sha...

 Polynovo Shares Continue to Decline Following CEO Departure

Polynovo Shares Continue to Decline Following CEO Departure

March 10, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Polynovo faces leadership change amid corporate governance issues.,Botanix sees growth in US pharmaceutical sales, boosting its market position.,EZZ secures a US partner for manufacturing dietary supplements, expanding its market reach.,Po...

 Botanix Joins ASX 300, Bolstering its Global Dermatology Ambitions

Botanix Joins ASX 300, Bolstering its Global Dermatology Ambitions

March 10, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Entry into S&P/ASX300,: Botanix Pharmaceuticals has secured a place in the S&P/ASX300 index, reflecting its growing presence in the pharmaceutical industry.,FDA-Approved Treatment,: Sofdra, an innovative gel for primary axillary hyperhidro...

 Health Kick Podcast: Imagion's Alternative Approach to Cancer Imaging

Health Kick Podcast: Imagion's Alternative Approach to Cancer Imaging

March 09, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Revolutionary Cancer Imaging,: Imagion Biosystems is enhancing non-invasive imaging solutions to improve accuracy in cancer detection.,Regulatory and Clinical Progress,: The company is preparing for the next phase of clinical trials and an...

 Cardiex Unveils Groundbreaking At-Home Heart Health Report

Cardiex Unveils Groundbreaking At-Home Heart Health Report

March 08, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Cardiex introduces a Cardiology Report in its CONNEQT app, offering clinical-grade insights into cardiovascular health.,The feature is designed to increase user engagement and expand the company's health data ecosystem.,With the new report...

 Lumos Diagnostics Holdings Limited's (ASX:LDX) Stock Price Falls by 29% Due to Subpar Performance

Lumos Diagnostics Holdings Limited's (ASX:LDX) Stock Price Falls by 29% Due to Subpar Performance

March 08, 2025 09:30 AM AEDT| By Team Kalkine Media

Highlights:,Lumos Diagnostics Holdings saw a sharp decrease in share price, reflecting market sentiment.,The company's price-to-sales ratio is lower than the industry average, indicating valuation differences.,Revenue growth presents mixed signals, w...

 NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Weak Performance is Resulting in a Low P/E Ratio

NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Weak Performance is Resulting in a Low P/E Ratio

March 08, 2025 09:30 AM AEDT| By Team Kalkine Media

Highlights,NeuroScientific Biopharmaceuticals (ASX:NSB) has a P/E ratio of 4.1x, considerably lower than the market average.,Impressive last year earnings growth might not meet long-term market expectations.,Market apprehensions are evident in the co...

 CSL Limited (ASX:CSL) is set to distribute a US$1.30 dividend in two days.

CSL Limited (ASX:CSL) is set to distribute a US$1.30 dividend in two days.

March 07, 2025 09:30 PM AEDT| By Team Kalkine Media

Highlights:,CSL Limited is approaching its ex-dividend date, an essential milestone for shareholders.,Dividend payments remain within sustainable payout ranges based on earnings and free cash flow.,Earnings and dividend growth have shown steady upwar...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.